The Effect of Celecoxib on Neuroinflammation in MDD
NCT04814355
·
clinicaltrials.gov ↗
PHASE4
Phase
COMPLETED
Status
41
Enrollment
OTHER
Sponsor class
Conditions
Major Depressive Disorder
Neuroinflammation
Interventions
DRUG:
Celecoxib 400 mg
Sponsor
Stony Brook University
Collaborators
[object Object]